The present invention relates to the three-dimensional ligand binding domain of the Glucagon receptor (GCGR) and its use in the identification and development of compounds for drug discovery and therapy. The invention further relates to methods of designing compounds.
申请公布号
WO2016030675(A1)
申请公布日期
2016.03.03
申请号
WO2015GB52455
申请日期
2015.08.26
申请人
HEPTARES THERAPEUTICS LIMITED
发明人
BORTOLATO, ANDREA;COOKE, ROBERT MATTHEW;DORÉ, ANDREW STEPHEN;KOGLIN, MARKUS;KRISHNAMURTHY, HARINI;LAMB, DANIEL JAMES;JAZAYERI-DEZFULY, SEYED ALI;MARSHALL, FIONA HAMILTON;ROBERTSON, NATHAN
